Stockscreener 앱 받기
1.716
0.23%
-0.004
전일 마감가:
$1.72
열려 있는:
$1.72
하루 거래량:
65,299
Relative Volume:
0.11
시가총액:
$116.94M
수익:
-
순이익/손실:
$-64.20M
주가수익비율:
-0.7981
EPS:
-2.15
순현금흐름:
$57,000
1주 성능:
-9.21%
1개월 성능:
-10.62%
6개월 성능:
+38.39%
1년 성능:
-41.03%
1일 변동 폭
$1.69
$1.735
1주일 범위
$1.635
$1.89
52주 변동 폭
$1.05
$3.21
Climb Bio Inc Stock (CLYM) Company Profile
명칭
Climb Bio Inc
전화
1-866-857-2596
주소
20 WILLIAM STREET, WELLESLEY HILLS
CLYM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.715 | 117.96M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.39 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
719.34 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.05 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.36 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.33 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 개시 | William Blair | Outperform |
| 2025-10-13 | 개시 | H.C. Wainwright | Buy |
| 2025-08-15 | 개시 | Robert W. Baird | Outperform |
| 2025-06-06 | 개시 | Oppenheimer | Outperform |
| 2025-05-22 | 개시 | BTIG Research | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
모두보기
Climb Bio Inc 주식(CLYM)의 최신 뉴스
Stocks of Korro Bio Inc (KRRO) are poised to climb above their peers - Setenews
Stocks of Upstream Bio Inc (UPB) are poised to climb above their peers - Setenews
Can Climb Bio Inc. stock withstand economic slowdown2025 Dividend Review & Risk Managed Investment Strategies - Newser
Is Climb Bio Inc. stock a safe investment in uncertain marketsTrade Entry Report & Low Risk Investment Opportunities - BỘ NỘI VỤ
Climb Bio, Inc. (CLYM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Climb Bio reports inducement grant under Nasdaq listing rule - MSN
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - markets.businessinsider.com
Brokerages Set Climb Bio, Inc. (NASDAQ:CLYM) Price Target at $9.20 - Defense World
Climb Bio (Nasdaq: CLYM) Announces Inducement Option for 120K Shares - Stock Titan
Climb Bio Inc (CLYM) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Published on: 2025-11-19 22:13:39 - newser.com
Is Climb Bio Inc. stock a buy on dipsMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
How sustainable is Climb Bio Inc. stock dividend payoutWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Is Climb Bio Inc. stock attractive after correctionQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Why Climb Bio Inc. stock is recommended by analystsInsider Selling & Accurate Buy Signal Alerts - newser.com
Predicting Climb Bio Inc. trend using moving averages2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Strategies to average down on Climb Bio Inc.2025 Big Picture & Capital Efficiency Focused Ideas - newser.com
Will Climb Bio Inc. stock go up soonRate Cut & High Win Rate Trade Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsForecast Cut & Stock Market Timing Techniques - newser.com
Momentum divergence signals in Climb Bio Inc. chart2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Has Climb Bio Inc. formed a bullish divergence2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Using R and stats models for Climb Bio Inc. forecastingJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Climb Bio, Inc. Reports Q3 2025 Financial Results - MSN
Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
What institutional flow reveals about Climb Bio Inc.Long Setup & Consistent Income Trade Ideas - newser.com
Is Climb Bio Inc (CLYM) positioned for future growth? - Setenews
Applied Therapeutics Inc (APLT) expanding its growth trajectory ahead - setenews.com
Climb Bio Inc (CLYM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Climb Bio Inc 주식 (CLYM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
0.05%
0.85%
자본화:
|
볼륨(24시간):